Back

Timing of treatment optimisation after left ventricular assist device implantation: Insights from the ENVAD-HF trial

10 May 2026 (14:55 - 16:12)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment (4) Ventricular Assist Devices HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Nina Jakus

University Hospital Centre Zagreb, Zagreb (Croatia)

6 More presentations in this session

Presentation thumbnail
End-diastolic aortic gap on initial cardiac ct and prognosis in lvad patients: comparison with echocardiographic aortic regurgitation
Ms M. Chao (Kaohsiung, TW)
Abstract Slides
Presentation thumbnail
Two-year event-free survival following heartmate 3 implantation: insights from a contemporary single-center cohort
Doctor T. Bajec (Ljubljana, SI)
Abstract Slides
Presentation thumbnail
Redefining echocardiographic optimization profile six months after LVAD implantation: the role of estimated right atrial pressure
Doctor J. Guzman Bofarull (London, GB)
Abstract Slides
Presentation thumbnail
Increased potassium requirement after LVAD implantation- may reflect increased RAAS activity
Doctor M. Zaleska-Kociecka (Warsaw, PL)
Abstract Slides
Presentation thumbnail
A novel transaortic microaxial ventricular assist device
Mr M. Yigit (Istanbul, TR)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment (4)

The Event

Event poster

Heart Failure 2026

10 May 2026 14:55 CET
You may be interested in
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources